Benjamin Cravatt
Director, KYNTRA BIO, INC.
Companies
- Alnylam PharmaceuticalsBoard member Jun 3, 2026 to now1
- KYNTRA BIO, INC.Board member Aug 7, 2020 to Jun 6, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- KYNTRA BIO, INC. KYNB28,736 shares3$154.0K at $5.36Jun 9, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 9, 2023Sold 2,178 shares at $17.51 of KYNTRA BIO, INC.3
- Jun 9, 2023Sold 1,766 shares at $16.75 of KYNTRA BIO, INC.3
- Jun 7, 2023Granted 8,289 shares of KYNTRA BIO, INC.3
- Jun 16, 2022Granted 15,777 shares of KYNTRA BIO, INC.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARKYNTRA BIO, INC., Board member
- 3
- 4SEC EDGARForm 4 filed Jun 21, 2022